Jennifer Taylor-Cousar, MD, MSCS

Articles by Jennifer Taylor-Cousar, MD, MSCS

Jennifer L. Taylor-Cousar, MD, MSCS, Professor, Departments of Medicine and Pediatrics, and codirector, Adult Cystic Fibrosis Program, and Director, Cystic Fibrosis Foundation Therapeutics Development Center, National Jewish Health

Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

ByJennifer Taylor-Cousar, MD, MSCS,Noah Stansfield

August 26th 2024

Jennifer L. Taylor-Cousar, MD, MSCS, a professor of internal medicine and pediatrics at National Jewish Health discussed updated data from the phase 1/2 AEROW trial of 4D-710.

Jennifer Taylor-Cousar, MD, MSCS, on Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

ByJennifer Taylor-Cousar, MD, MSCS

July 9th 2024

The professor of internal medicine and pediatrics at National Jewish Health discussed updated data from the phase 1/2 AEROW trial of 4D-710.

Jennifer Taylor-Cousar, MD, MSCS

Articles by Jennifer Taylor-Cousar, MD, MSCS

Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

Jennifer Taylor-Cousar, MD, MSCS, on Early Signals of Efficacy With Cystic Fibrosis Gene Therapy

Latest Updated Articles

Trending on CGTlive®

FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma

Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease

FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma

Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings

CGTLive®’s Weekly Rewind – December 5, 2025